IRIS
BALDUINI, CARLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.101
EU - Europa 4.461
AS - Asia 3.441
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 16
AF - Africa 9
SA - Sud America 4
Totale 14.052
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.043
CN - Cina 3.364
IE - Irlanda 1.473
UA - Ucraina 789
FI - Finlandia 644
DE - Germania 431
SE - Svezia 428
IT - Italia 288
GB - Regno Unito 215
FR - Francia 102
CA - Canada 57
IN - India 34
BE - Belgio 25
IR - Iran 18
RO - Romania 17
EU - Europa 15
AU - Australia 14
RU - Federazione Russa 13
NL - Olanda 11
MU - Mauritius 8
GR - Grecia 7
SG - Singapore 7
NZ - Nuova Zelanda 6
TR - Turchia 5
DK - Danimarca 4
PT - Portogallo 4
JP - Giappone 3
KZ - Kazakistan 3
AR - Argentina 2
BR - Brasile 2
CH - Svizzera 2
CZ - Repubblica Ceca 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AT - Austria 1
BD - Bangladesh 1
ET - Etiopia 1
IL - Israele 1
IQ - Iraq 1
KH - Cambogia 1
KR - Corea 1
MD - Moldavia 1
MY - Malesia 1
NO - Norvegia 1
PA - Panama 1
PH - Filippine 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 14.052
Salva come PNG Salva come JPEG
Città #
Dublin 1.471
Chandler 1.361
Jacksonville 1.156
Nanjing 1.034
Ashburn 438
Nanchang 419
Princeton 311
Shenyang 302
Changsha 294
Wilmington 293
Medford 291
Lawrence 289
Hebei 287
Beijing 237
Jiaxing 223
Tianjin 159
Hangzhou 157
Ann Arbor 138
Boardman 129
Helsinki 124
Woodbridge 70
Milan 69
Pavia 53
Houston 46
New York 44
Norwalk 43
Shanghai 43
Verona 42
Fairfield 38
Toronto 37
Seattle 28
Brussels 25
Los Angeles 23
Ningbo 22
Des Moines 20
Zhengzhou 20
Jinan 19
Auburn Hills 16
Guangzhou 16
Pune 16
Taizhou 14
Timisoara 12
Dearborn 11
Falls Church 11
Kunming 11
Fuzhou 10
San Francisco 10
Rome 9
Tappahannock 9
Washington 9
Munich 8
Orange 8
Andover 7
Melbourne 7
Redwood City 7
Ardabil 6
Changchun 6
Lanzhou 6
Leawood 6
Singapore 6
Borås 5
Chongqing 5
Monmouth Junction 5
Hamilton 4
London 4
Padova 4
Palermo 4
Tehran 4
Bologna 3
Chicago 3
Ottawa 3
Plymouth 3
Preston 3
Sacramento 3
Aprilia 2
Brescia 2
Buffalo 2
Caserta 2
Casorate Sempione 2
Edmonton 2
Falkenstein 2
Fayetteville 2
Frankfurt am Main 2
Genoa 2
Haarlem 2
Haikou 2
Indianapolis 2
Lachine 2
Margherita Di Savoia 2
Moscow 2
Nanaimo 2
Orero 2
Paris 2
Parma 2
Pieve Emanuele 2
Pisa 2
Porto 2
Redmond 2
Sydney 2
Teramo 2
Totale 10.081
Salva come PNG Salva come JPEG
Nome #
Antigeni minori di istocompatibilità 116
Activation of the haemostatic process in patients with unruptured aortic aneurysm before and after surgical repair 80
Gout, allopurinol intake and clinical outcomes in the hospitalized multimorbid elderly. 80
Abdominal lymphographic pattern in connective tissue diseases is quite similar to that observed in lymphocytic lymphoma. 79
Effect of platelet GP llb-llla complex occupancy on early stages of platelet activation 79
Anomalous erythrocytes produced by rabbits with liver damage. 78
The myelodysplastic syndromes: predictive value of eight prognostic systems in 143 cases from a single institution. 78
Spectrum of the mutations in Bernard-Soulier syndrome. 77
Screening for congenital bleeding disorders with platelet function analyzer (PFA-100) in women with menorrhagia 77
Platelet diameters in inherited thrombocytopenias: analysis of 376 patients with all known disorders. 76
Heparin modifies platelet count and function in patients who have undergone thrombolytic therapy for acute myocardial infarction. 74
IN VIVO AND IN VITRO EFFECTS OF THROMBOLYTIC AGENTS ON PLATELET COMPOSITION AND FUNCTION 74
Gender-differences in disease distribution and outcome in hospitalized elderly: Data from the REPOSI study 73
Aggregation of human platelets stimulates calcium ion movement and release reaction. 72
A G to C transversion at the last nucleotide of exon 25 of the MYH9 gene results in a missense mutation rather than in a splicing defect. 72
ACTN1-related thrombocytopenia: identification of novel families for phenotypic characterization. 72
Thrombopoietin is not uniquely responsible for thrombocytosis in inflammatory disorders 71
Autoimmunità e piastrinopatie [Autoimmunity and platelet disorders] 70
Prophylaxis of venous thromboembolism in elderly patients with multimorbidity 70
Ageing of rabbit red cells in vitro: membrane modifications and their possible role in red cell survival in vivo. 69
Spontaneous long-lasting remission in a young patient with angioimmunoblastic lymphadenopathy with dysproteinemia. 68
MYH9-related disease: five novel mutations expanding the spectrum of causative mutations and confirming genotype/phenotype correlations. 68
Ubiquitin/proteasome-rich particulate cytoplasmic structures (PaCSs) in the platelets and megakaryocytes of ANKRD26-related thrombo-cytopenia. 68
Effect of low molecular weight heparin on some markers of platelet and thrombin activation in patients with inflammatory bowel diseasesnresponsive to the standard therapy 68
Thrombocytopenia, giant platelets, and leukocyte inclusion bodies (May-Hegglin anomaly). Clinical and laboratory findings. 67
Osteomalacia ipofosfatemica secondaria ad emangiopericitoma sottocutaneo. Studio clinico ed istopatologico di un caso. 67
Absence of CYCS mutations in a large Italian cohort of patients with inherited thrombocytopenias of unknown origin. 67
Effetti sistemici della terapia trombolitica.[Systemic effects of thrombolytic therapy]. 66
[Idiopathic myelodysplastic syndromes. A caseload contribution]. 66
NITROGLYCERIN INFUSION - HEMODYNAMIC AND ANTI-PLATELETS EFFECTS IN PATIENTS WITH CARDIOMYOPATHY 66
β-1 tubulin R307H SNP alters microtubule dynamics and affects severity of a hereditary thrombocytopenia. 66
MYH9 related disease: four novel mutations of the tail domain of myosin-9 correlating with a mild clinical phenotype. 66
Autologous transfusion of thrombosol plus low-dose DMSO cryopreserved platelet concentrates (PCs) for severe thrombocytopenia following high-dose chemotherapy (HDC). 65
A Leu40Pro substitution in the leucine rich motif (LRM) of glycoprotein (GP) IX is responsible for dysfunction of a normally expressed GPIB alpha in Bernard-Soulier syndrome (BSS) 65
A new variant of Bernard-Soulier syndrome characterized by dysfunctional glycoprotein (GP) IB and severely reduced amounts of GPIX and GPV. 64
Confronto di due metodi di criopreservazione piastrinica basati sull'impiego di glicerolo-glucosio o DMSO: studio della funzionalità piastrinica in vitro. 64
Autologous cryopreserved platelets can efficiently support patients with breast cancer after high-dose chemotherapy and circulating progenitor cell transplantation 64
Lessons in platelet production from inherited thrombocytopenias. 64
Mutations responsible for MYH9-related thrombocytopenia impair SDF-1-driven migration of megakaryoblastic cells. 63
Adhesive receptors, extracellular proteins and myosin IIA orchestrate proplatelet formation by human megakaryocytes. 63
Severe platelet disfunction in a patient with autoantibodies against membrane glycoproteins IIb-IIIa 63
Clinical and pathogenetic characterization of ETV6-related thrombocytopenia (ETV6-RT), an inherited thrombocytopenia (IT) predisposing to childhood acute lymphoblastic leukemia (ALL) 63
Donor-recipient incompatibility at CD31-codon 563 is a major risk factor for acute graft-versus-host disease after allogeneic bone marrow transplantation from a human leucocyte antigen-matched donor. 62
Inherited thrombocytopenias: from genes to therapy. 62
Platelet composition and function in patients undergoing cardiopulmonary bypass for hearth surgery. 62
Splenectomia in corso di porpora trombocitopenica idiopatica: fattori prognostici e risultati clinici. 62
PLASMA PROTEIN-Z LEVELS AND HEMOSTASIS IN PATIENTS ON DICUMAROL TREATMENT AND IN PATIENTS WITH BLEEDING TENDENCY OF UNKNOWN ORIGIN 62
Transfection of the mutant MYH9 cDNA reproduces the most typical cellular phenotype of MYH9-related disease in different cell lines. 62
Analysis of 339 pregnancies in 181 women with 13 different forms of inherited thrombocytopenia 62
Transfusion of platelet concentrates cryopreserved with thromboSol plus low-dose dimethilsulphoxide in patients with severe thrombocytopenia: a pilot study 61
Immunocytochemistry for the heavy chain of the non-muscle myosin IIA as a diagnostic tool for MYH9-related disorders. 61
Application of a diagnostic algorithm for inherited thrombocytopenias to 46 consecutive patients. 61
Effect of 52 monoclonal antibodies against platelet membrane on platelet aggregation and release reaction 61
Platelet function after 'in vivo' and 'in vitro' treatment with thrombolytic agents. 61
Recent advances in the understanding and management of MYH9-related inherited thrombocytopenias. 61
Acute granulocytic leukemia with Alder-Reilly inclusions. 61
Altered cytoskeleton organization in platelets from patients with MYH9-related disease. 61
A modified high-dose dexamethasone regimen for primary systemic amyloidosis 60
An atypical myeloproliferative disorder with high thrombotic risk and slow disease progression. 60
Glycopeptides of erythrocyte membranes in some hematological disorders 60
Desmopressin and platelets: In vitro and in vivo studies 60
CYCLIC THROMBOCYTOPENIA-THROMBOCYTOSIS WITH A PERIODIC DEFECT OF PLATELET-FUNCTION - REPORT OF A CASE 60
High versus standard dose methylprednisolone in the acute phase of idiopathic thrombotic thrombocytopenic purpura: a randomized study. 60
THE D1424N AND R1933X MUTATIONS OF MYH9 CAUSE THROMBOCYTOPENIA THROUGH LOSS OF REGULATION OF PROPLATELET FORMATION BY TYPE I COLLAGEN. 60
Cryopreservation of human platelets using dimethyl sulfoxide and glycerol-glucose: effects on "in vitro" platelet function. 59
Application of a Diagnostic Algorithm for Inherited Thrombocytopenia Patients in the Setting of a Developing Country. 59
Platelet predeposit and transfusion in patients receiving high-dose chemotherapy and autologous transplant for breast cancer 59
May-Hegglin anomaly: Clinical and laboratory investigation of 14 cases 59
Inherited thrombocytopenias: a proposed diagnostic algorithm from the Italian Gruppo di Studio delle Piastrine 59
Comparison of disease clusters in two elderly populations hospitalized in 2008 and 2010. 59
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 59
Platelet count and aging 58
Thrombopoietin levels in patients with primary and reactive thrombocytosis. 58
Expression, activation, and subcellular localization of the Rap1 GTPase in cord blood-derived human megakaryocytes. 58
International prognostic scoring system and other prognostic systems for myelodysplastic syndromes. 58
Haemophagocytic syndrome responding to high-dose gamma-globulin as presenting feature of sarcoidosis. 58
A modified technique for therapeutic leukapheresis using a discontinuous flow. 58
Acquired immune thrombastenia: a new bleeding disorder. 58
Incompatibility at CD31, HPA3 or HPA5 loci are HLA-A2-restricted risk factors for acute GVHD. 58
Inherited thrombocytopenias. The evolving spectrum. 58
Short-term eltrombopag for surgical preparation of a patient with inherited thrombocytopenia deriving from MYH9 mutation. 58
In vitro and in vivo effects of desmopressin on platelet function 58
Factors influencing post-transfusional platelet increment in pediatric patients given hematopoietic stem cell transplantation. 57
Possible evolution of human parvovirus B19 infection into erythroleukemia 57
Platelet size distinguishes between inherited macrothrombocytopenias and immune thrombocytopenia. 57
International prognostic scoring system (IPSS) and other prognostic systems for myelodysplastic syndromes (MDS). 57
The Case. Proteinuria and low platelet count. 57
NOVEL PERSPECTIVES IN GENOTYPE-PHENOTYPE CORRELATIONS IN MYH9-RELATED DISEASE: NO LONGER JUST A MATTER OF HEAD OR TAIL 57
Ristocetin-induced platelet agglutination stimulates GPIIb-IIIa-dependent calcium influx. 56
Defect of platelet aggregation and adhesion induced by autoantibody against glycoprotein IIIa. 56
Expression, activation and subcellular localization of the Rap1 GTPase in human cord blood-derived megakaryocytes 56
Behaviour of young and old desialylated rabbit erythrocytes in vivo. 56
Hyperhomocysteinemia and FV ARG 506 GLN in 81 consecutive patients with thrombosis. 56
Personalized reference intervals for platelet count reduce the number of subjects with unexplained thrombocytopenia 56
Autosomal dominant thrombocytopenias with reduced expression of glycoprotein Ia 56
Heparin infusion facilitates ex vivo platelet aggregation in patients with acute myocardial infarction who have undergone thrombolytic therapy. 56
Incompatibility for CD31 and human platelet antigens and acute graft-versus-host disease after bone marrow transplantation 55
Von Willebrand disease type 2B must be always considered in the differential diagnosis of genetic thrombocytopenias with giant platelets. 55
Giant platelet syndromes and the MYH9 mutations 55
Defective platelet responsiveness to thrombin and protease-activated receptors agonists in a novel case of gray platelet syndrome: correlation between the platelet defect and the alpha-granule content in the patient and four relatives. 55
Totale 6.381
Salva come PNG Salva come JPEG
Categoria #
all - tutte 48.912
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.912
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201957 0 0 0 0 0 0 0 0 0 0 6 51
2019/20203.914 1.200 1.717 7 144 2 166 59 164 20 317 112 6
2020/20211.625 171 138 53 148 8 223 10 265 86 257 211 55
2021/20221.399 25 0 47 24 51 51 25 82 70 47 182 795
2022/20234.032 452 242 25 354 398 434 7 209 1.706 24 99 82
2023/20241.184 168 212 42 130 124 334 23 89 9 50 3 0
Totale 14.644